Contrast Media Injectors Market
Number of pages: 100 | Report Format: PDF | Published date: June 03, 2021
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 1.56 billion |
|
Revenue Forecast in 2031 |
US$ 2.99 billion |
|
CAGR |
7.5 |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global contrast media injectors market was valued at US$ 1.56 billion in 2022 and is expected to register a revenue CAGR of 7.5% to reach US$ 2.99 billion in 2031.
Contrast Media Injectors Market Fundamentals
Devices used to inject contrast media into the body for imaging purposes are referred to as contrast media injectors or contrast delivery systems. Computed tomography (CT) and magnetic resonance imaging (MRI) treatments use these injectors heavily. During imaging operations, contrast media are substances injected into the body to make internal organs, blood vessels, and tissues more visible. The clarity and precision of the images obtained can be enhanced by using contrast media injectors since they give users precise control over the injection volume, rate, and timing. Power injectors, dual-head injectors, and syringe injectors are just a few of the different types and designs of contrast media injectors that are offered.
One of the most significant developments is the creation of intelligent injectors, which can automatically modify the injection parameters following the patient's characteristics and the imaging protocol. These injectors evaluate patient data using artificial intelligence and machine learning algorithms, improving image quality and patient safety. Integrating contrast media injectors with imaging systems, which permits real-time monitoring and adjusting of the injection parameters throughout the imaging procedure, is another noteworthy development. Due to this integration, the injector and imaging system can communicate without interruption, which can lower the possibility of mistakes and boost productivity.
[735224]
Contrast Media Injectors Market Dynamics
One of the main factors propelling the contrast media injectors market growth is the rising need for minimally invasive diagnostic and imaging treatments. A research paper published by the National Institute of Health states that, in upcoming years, it is reasonable to assume that more than 80% of surgical procedures will be carried out using some minimally invasive technique, with the majority being performed on an outpatient basis. Because they have a lower risk of problems, quicker recovery periods, and lower costs than invasive treatments like surgical biopsies, minimally invasive techniques like CT scans and MRI are favored by making it possible to administer contrast media precisely and under control, contrast media injectors play a crucial part in these minimally invasive treatments by raising the precision and caliber of the images that are captured. By enabling real-time modifications during the imaging process, contrast media injectors can also enhance the clarity and accuracy of the images.
The need for contrast media injectors is anticipated to increase with the introduction of cutting-edge imaging techniques, including cone-beam computed tomography (CBCT) and digital breast tomosynthesis (DBT). To produce high-quality images using these modern imaging methods, contrast media must be used, and contrast media injectors are essential for the regulated and exact delivery of the contrast media. For instance, CBCT is a type of CT scan that produces finely detailed 3D images of the mouth, teeth, and jaw using an X-ray beam with a cone shape. In CBCT imaging, contrast media are frequently employed to make soft tissues and blood arteries more visible. Like mammography, DBT creates a 3D image of the breast tissue, increasing the precision of finding breast cancer. In DBT imaging, a contrast medium is frequently used to make tiny breast lesions and other abnormalities more visible. The demand for contrast media injectors is anticipated to rise as these cutting-edge imaging technologies are widely used, propelling the market's expansion.
However, the prohibitive price of contrast media injectors may prevent widespread use, especially in developing nations. The expensive maintenance and service of contrast media injectors may also raise the total cost of ownership. For instance, the price difference between the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector - Pedestal Mount and the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector - Ceiling Mount for Long is about USD 40,600. As tubes and syringes cost between USD 350 and USD 500, using contrast media injector devices becomes more expensive, which is a significant hardship for end users. Another difficulty is the possibility of severe reactions to contrast media, such as allergic reactions, which can have major consequences and raise the risk of mortality. Due to this, patients may become reluctant to undergo imaging treatments that call for contrast media. The market development for contrast media injectors may also be constrained by the availability of substitute imaging techniques that do not require contrast material, such as ultrasound. Finally, a problem with imaging procedures is that they may not be operated or interpreted by qualified specialists.
Contrast Media Injectors Market Ecosystem
The global contrast media injectors market overview is analyzed from the following perspectives: product, application, end user, and region.
Contrast Media Injectors Market by Product
Based on the products the global contrast media injectors market is segmented into consumables and accessories. The consumables segment is further sub-segmented into syringes, tubes, injector heads, and others. The injector systems segment is further sub-segmented into the angiography injector system, CT injector system, and MRI injector system.
The consumables segment accounted for the largest revenue share of the global contrast media injectors market in 2022. The consumable segment, which includes syringes, tubing, and other disposable components used in contrast media injectors, dominates the contrast media injectors market due to the high frequency of use and the need for replacement during imaging procedures. These consumables are typically single-use and must be disposed of after each use, creating a continuous demand for replacements. As a result, the consumable segment generates a significant proportion of revenue for contrast media injector manufacturers and suppliers. Additionally, the consumable segment is less expensive than the capital equipment segment, including the contrast media injectors. This lower cost can make the consumable segment more attractive to healthcare facilities with limited budgets or those seeking to reduce their capital expenditures. Overall, the high demand and need for replacing consumables used in contrast media injectors make the consumable segment dominant in the market.
Contrast Media Injectors Market By Application
[98655324]
Based on application, the contrast media injectors market is segmented into radiology, interventional cardiology, and other applications.
Due to the rising frequency of cardiovascular disorders and the rising need for less invasive diagnostic and therapeutic procedures, interventional cardiology has become the market leader for contrast media injectors. Contrast media injectors are necessary for interventional cardiology procedures, including angiography, angioplasty, and stenting to view blood arteries and spot blockages or other abnormalities. A larger need for interventional cardiology procedures, which has increased demand for contrast media injectors, has been caused by the rising incidence of cardiovascular disorders such as coronary artery disease and peripheral artery disease. The need for contrast media injectors is also fueled by improvements in imaging techniques like digital subtraction angiography (DSA) and rotational angiography, which have increased blood vessel visibility.
Contrast Media Injectors Market By End User
Based on end users, the contrast media injectors market has been segmented into hospitals, diagnostic centers, and others.
The hospital's segment accounted for the highest revenue share of the global contrast media injectors market in 2022. The hospital segment dominates the contrast media injectors market as hospitals are the primary healthcare providers performing imaging procedures such as CT scans, MRIs, and angiography, which require contrast media injectors. Moreover, hospitals typically have larger budgets and more resources than other healthcare facilities, making it easier to invest in capital equipment such as contrast media injectors. Hospitals often have a larger patient volume than other healthcare facilities, requiring more imaging procedures and, therefore, a higher volume of contrast media injectors. Also, hospitals tend to have specialized departments, such as radiology and cardiology, which require a higher volume of imaging procedures and contrast media injectors. All these factors combined make the hospitals segment the dominant segment in the contrast media injectors market.
Contrast Media Injectors Market by Region
Based on the region, the global contrast media injectors market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the largest revenue share of approximately 40% of the global contrast media injectors market in 2022. With high levels of technological adoption and financial support for healthcare innovation, the area has a well-developed healthcare infrastructure. Consequently, there is a supportive regulatory environment for contrast media injectors, including laws encouraging their creation and uptake. Furthermore, the increasing prevalence of chronic diseases in the region is fueling market growth. In North America, managing chronic diseases is a major emphasis, and contrast media injectors have been essential to advancing this cause. According to CDC, an estimated 20.4% (50.0 million) of American adults reported having chronic pain, and 8.0% (19.6 million) reported having high-impact chronic pain. Women, older adults, people who had jobs in the past but are no longer doing so, people who live in poverty, people who have public health insurance, and people who live in rural areas were found to have a higher prevalence of both chronic pain and high-impact chronic pain.
Contrast Media Injectors Market Competitive Landscape
Multiple companies across the globe are investing in research and development, which is expected to improve the contrast media injectors market outlook. Notable market participants account for the largest revenue share of the global contrast media injectors market include,
Contrast Media Injectors Market Strategic Developments
Contrast media injectors are devices that inject contrast agents into the patient's body to enhance the visibility of internal organs and tissues during medical imaging procedures.
The rise in chronic disease prevalence, advancements in the healthcare industry, and government initiatives to improve healthcare are the key drivers of the global contrast media injectors market.
Key companies operating the global contrast media injectors market are Bayer, Bracco Imaging S.p.A., Nemoto Kyorindo Co., Ltd., Ulrich GmbH & Co. KG, and Shenzhen Anke High-tech Co., Ltd.
The restraining factors of the global contrast media injectors market are the inflated cost of contrast media injectors devices, the risk of compromise, and lower patient awareness.
The global contrast media injectors market is expected to witness a CAGR of 7.4% during the forecast period from 2022 to 2030.
North America accounts for the largest revenue share in the global contrast media injectors market.
*Insights on financial performance are subject to the availability of information in the public domain